Wait, That's How Scott Pelley Reacted to His Firing From CBS News?
Iranian Dual Citizen Busted for Supplying Equipment to Tehran
The Scott Pelley Saga Is Over at CBS News, but Not the Melodramatics...
New 'American Options Doctrine' Would Transform US-Israel Relations
The Associated Press Is Married to Protecting Islam at Any Cost
Scott Pelley and Bari Weiss Respond to Pelley's Termination From CBS
California’s New Congressional Map May Have Just Backfired on Gavin Newsom
This Democrat Just Stormed Out of Marco Rubio's House Hearing
Katie Porter Falls Flat in California's Gubernatorial Race
Democrats' Maine Senate Gamble Raises Questions About Standards
'Reconciliation 3.0' Is Almost Here – And It Might Include the SAVE America Act
Four Republicans Join Democrats As U.S. House Passes Iran War Powers Resolution
Detransitioner Chloe Cole Testifies on Devastating Effects of Transition
Kansas Woman Sentenced for $450K Benefits Fraud Using Dead Relative’s Identity
Yes, People Still Voted for Eric Swalwell
Tipsheet

Pfizer CEO: Our Vaccines Offer ‘Limited, If Any Protection’

Pfizer CEO: Our Vaccines Offer ‘Limited, If Any Protection’
AP Photo/Pablo Martinez Monsivais, File

Speaking during remarks to a J.P. Morgan healthcare conference this week, Pfizer CEO Albert Bourla openly stated current vaccines the company developed for Wuhan coronavirus offer "limited, if any" protection against contracting current variants of the disease. He then encouraged booster shots. 

The statement from Bourla comes as the Biden administration continues to justify vaccine mandates for federal workers, contractors and private businesses. The Supreme Court heard arguments about President Biden's mandates for private companies and medical workers last week. A ruling is expected soon on the constitutionality of the mandates. 

A number of people who have pointed out the waning efficacy of Pfizer's vaccines, which Bourla touted last year as being "100 percent" effective against contracting or transmitting the virus, have been banned by social media companies. 

Meanwhile, Bourla also announced this week the company is developing a vaccine specific to Omicron. It is expected to be ready in March when health officials predict the latest wave of the mild variant will already be over. 

Join the conversation as a VIP Member

Recommended

Trending on Townhall Videos